Analyst Conference Summaries

Biotechnology Investor Aids

Sage Therapeutics
SAGE

conference date: August 3, 2021 @ 5:00 AM Pacific Time

Sage Therapeutics' Deal With Biogen Should Revive It [December 11, 2020 at Seeking Alpha]

Click on summary links for quarterly earnings results, news, and management commentary. I am covering it because I own stock in Biogen, which is becoming a collaborator and investor.

2021
Sage
Therapeutics
Q1 2021
Sage
Therapeutics
Q2 2021
   
May 4, 2021 Aug. 3, 2021    
2020
    Sage
Therapeutics
Q3 2020
Sage
Therapeutics
Q4 2020
    Nov. 5, 2020 Feb. 24, 2021

Sage Therapeutics (SAGE) is a commercial stage biotechnology company specializing in therapies for brain disorders.

Sage Therapeutics web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 BIIB
 BMY
 CLDX
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SGEN
 VBLT
 VSTM
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers